Agios Pharmaceuticals Inc P/E Adelante
¿Qué es el P/E Adelante de Agios Pharmaceuticals Inc?
El P/E Adelante de Agios Pharmaceuticals Inc es -3.82
¿Cuál es la definición de P/E Adelante?
La relación precio a futuro es la relación entre el precio de las acciones de una empresa y las ganancias por acción estimadas de la compañía para los próximos doce meses.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
P/E Adelante de compañías en Sector Health Care en NASDAQ en comparadas con Agios Pharmaceuticals Inc
¿Qué hace Agios Pharmaceuticals Inc?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Empresas con p/e adelante similar a Agios Pharmaceuticals Inc
- Peloton Interactive Inc tiene P/E Adelante de -3.88
- aap Implantate AG tiene P/E Adelante de -3.84
- Pharnext SA tiene P/E Adelante de -3.84
- Tinka Resources tiene P/E Adelante de -3.83
- Trilogy International Partners tiene P/E Adelante de -3.82
- Midas Gold tiene P/E Adelante de -3.82
- Agios Pharmaceuticals Inc tiene P/E Adelante de -3.82
- Recon Technology Ltd tiene P/E Adelante de -3.80
- Ballard Power Systems tiene P/E Adelante de -3.79
- comScore tiene P/E Adelante de -3.78
- Avenue Therapeutics Inc tiene P/E Adelante de -3.74
- Compugen Ltd tiene P/E Adelante de -3.73
- Vir Biotechnology Inc tiene P/E Adelante de -3.70